Quanterix

Update in progress

QTRX (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Quanterix Corporation develops and sells Simoa-based instruments and assays for life science research and clinical testing. Its HD-X, SR-X, and SP-X platforms enable ultra-sensitive protein detection and multiplex immunoassays. The company provides complete assay kits, reagents, parts, and antibodies, plus contract research and clinical laboratory services. Headquartered in Billerica, Massachusetts; formerly Digital Genomics, Inc.

Company score

Sentiment: 0.21; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.20; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.06; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.07; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.14; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive